Convexity Labs

BG

Convexity Analyst · BG
Buymedium confidenceTactical · no named thesis
Generated Jun 21, 2026

ANALYST NOTE: Bunge Global S.A. (BG) Date: 2026-06-13 Current Price: $112.58

1. Structural Readiness

State: Context-Only (Forming Coil)

  • Conservative Entry: Not yet defined (awaiting confirmed breakout).
  • Aggressive/Pre-Breakout Entry: N/A (Current price is not a defined entry point for a confirmed setup; it is a holding zone).
  • Breakout Level: Pending confirmation. A close above the established resistance of the current consolidation range is required to fire the setup.
  • Current Price: $112.58.
  • Extension: Not applicable (price is within the consolidation range, not extending beyond a breakout).
  • ATR Context: Current ATR is 3.7% (Productive). This sits within the historical "sweet spot" (4–6% is ideal, but 3.7% indicates healthy, tradable volatility without the extreme risk of >8% noise).

2. Thesis Layer

Thesis Status: TACTICAL / Setup-Led Macro Thesis: None named at this date.

This is a tactical, setup-led name. There is no named secular macro thesis driving the immediate setup. The conviction must be derived strictly from the quality of the structural setup (the forming coil) and the underlying business fundamentals as reported by management. We do not invent a thesis; we judge the name on the strength of the evidence provided in the earnings transcripts and filings relative to the current price action.

3. Business Overview

Company: Bunge Global S.A. Industry: Agribusiness / Food & Feed / Biofuels Business Model: Bunge operates as a globally integrated agribusiness and food corporation. The company sources, stores, transports, processes, and sells agricultural commodities and their derivatives.

Key Segments & Operations (as of 2026):

  • Soybean Processing and Refining: A globally integrated business purchasing, crushing, and refining soybeans. In Q1 2026, this segment reported Adjusted EBIT of $661 million, up from $406 million in the prior year, driven by stronger processing performance in Argentina and Brazil.
  • Softseed Processing and Refining: Handles other oilseeds.
  • Tropical Oils: Benefits from rising oil prices; management noted higher sales prices in this segment were driven by "rising oil prices from the conflict with Iran" and global biofuel mandates.
  • Specialty Ingredients: Includes the recently acquired assets from International Flavors & Fragrances (IFF).
  • Grain Merchandising and Milling: Serves global demand for protein (poultry/pork) and provides milled products including whole grains, fiber, and specialty grains (quinoa, millet).
  • Sugar and Bioenergy: Produces sugar and ethanol.

Recent Strategic Moves (Management Expectations):

  • Acquisition of IFF Assets: On March 1, 2026, Bunge closed the acquisition of IFF's soy protein, lecithin, and processing business for $105 million. This expands their Specialty Ingredients footprint.
  • Viterra Integration: The acquisition of Viterra Limited was completed on July 2, 2025, for approximately $5.3 billion in stock and $1.9 billion in cash. Management views this as creating a "premier global agribusiness solutions company."
  • Divestiture: The sale of the European margarines and spreads business to Vandemoortele Lipids NV is expected to close in 2026 for approximately $239 million.
  • Future M&A: An agreement to acquire Solae assets (lecithin, soy protein) was entered into August 2025, expected to close in 2026.

4. Archetype and Conviction

Archetype: Cyclical Recovery Fit: The setup fits the "Cyclical Recovery" archetype. The company is navigating a post-acquisition integration phase (Viterra, IFF) while benefiting from a cyclical upswing in commodity prices (tropical oils, soybeans) and favorable regulatory environments (EPA RVO decision supporting biofuels).

Fundamental Strengths (Evidence-Based):

  • Guidance Upgrade: Management raised full-year 2026 adjusted EPS guidance to $9.00 – $9.50, up from the previous $7.50 – $8.00 range. This indicates strong operational leverage and margin expansion.
  • Tax Efficiency: Adjusted effective tax rate expected to be 22% – 26%, down slightly from the prior 23% – 27% range.
  • Segment Performance: The Soybean Processing segment saw EBIT jump to $661 million (vs. $406 million prior year).
  • Biofuel Tailwinds: Management explicitly commended the EPA's RVO decision, noting it supports investments in biofuel supply chains, a key revenue driver for the company.

Valuation & Financial Spine:

  • Forward Consensus: FY1 EPS consensus is $9.15; FY2 is $10.95.
  • Current Price Context: At $112.58, the stock trades at approximately 12.3x FY1 consensus EPS. Given the guidance upgrade to $9.00–$9.50, the stock is trading near the midpoint of the new guidance range on a forward basis, suggesting the market is pricing in the recovery but not yet fully pricing in the upside to the high end of the range ($9.50) or the FY2 growth ($10.95).

Conviction Stack:

  • Thesis Strength: Moderate (Tactical, no macro thesis).
  • Evidence Quality: High (Clear guidance upgrades, specific segment earnings, completed acquisitions).
  • Structural Quality: Moderate (Forming coil, not yet confirmed breakout).
  • Rerating Potential: Moderate to High (Depends on breakout confirmation and realization of FY2 growth).

5. Invalidations, Strengtheners, and Gaps

What Would Invalidate:

  • A significant downgrade in full-year guidance (e.g., cutting EPS below $8.00) due to commodity price collapses or integration failures.

What Would Strengthen:

  • A confirmed breakout above the current consolidation resistance (price action firing the setup).
  • Further confirmation of the "Cyclical Recovery" via continued strong EBIT in the Soybean Processing segment.
  • Successful closing of the Solae acquisition and the Vandemoortele divestiture as expected in 2026.

Gaps in Evidence:

  • Debt Servicing Details: While Net Interest Expense is guided at $620M–$660M (up from $575M–$625M), the specific impact of the $5.3B Viterra stock issuance on long-term leverage ratios is not detailed in the provided snippets.
  • Integration Synergies: The specific dollar value of synergies expected from the Viterra and IFF acquisitions is not quantified in the provided text, only the strategic intent.

PRIVATE ANALYST CALL

Judgment: Buy Confidence: medium Key evidence: Management raised full-year 2026 adjusted EPS guidance to $9.00-$9.50 from $7.50-$8.00; Soybean Processing EBIT surged to $661 million from $406 million year-over-year; Stock trades near FY1 consensus ($9.15) with FY2 growth expected to reach $10.95. Sizing hint: Position size should reflect the "Forming" status—smaller than a confirmed breakout, but larger than a speculative guess, acknowledging the 69% historical breakout probability of this structure. Expected path: Management expects continued strength in South American processing and biofuel demand; the stock likely consolidates near current levels until a breakout above resistance confirms the setup, potentially re-rating toward the high end of the $9.50 EPS guidance. Expected horizon: 3 to 6 months for the setup to resolve (breakout or invalidation).

Loading chart...
Exhibit 1: BG daily candlestick — no active setup overlay.

Source-backed evidence anchors and catalysts land once Convexity finishes coverage for BG.

Core assumptions for this name haven't been articulated yet — they land alongside the rerating thesis.

Value picture unavailable — no financial spine on file for BG.

Layer B fundamentals snapshot not yet available. Highlights land once Convexity finishes the classification.

Coverage: